Acurx Pharmaceuticals, Inc. Share Price
ACXPAcurx Pharmaceuticals, Inc. Stock Performance
Open $2.71 | Prev. Close $2.81 | Circuit Range N/A |
Day Range $2.71 - $2.71 | Year Range $2.71 - $21.00 | Volume 200 |
Average Traded $2.71 |
Acurx Pharmaceuticals, Inc. Share Price Chart
About Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Acurx Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
08-Jan-26 | $2.98 | $2.97 | +1.37% |
07-Jan-26 | $3.16 | $2.93 | +0.00% |
06-Jan-26 | $2.93 | $2.93 | +3.17% |
05-Jan-26 | $2.84 | $2.84 | +3.46% |
02-Jan-26 | $2.75 | $2.75 | -0.18% |
30-Dec-25 | $2.81 | $2.75 | -15.90% |
26-Dec-25 | $3.36 | $3.27 | -6.03% |